Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S A Murphy

Showing results (91-100 of 102) with videos related to

Pageof 11
Sort By:
Transactions of the Royal Society of Tropical Medicine and Hygiene|May 1, 1997
The disposition of intramuscular artemether in children with cerebral malaria; a preliminary studyS A Murphy, E Mberu, D Muhia, et al.
The American Journal of Cardiology|May 30, 2001
Effect of eptifibatide on coronary flow reserve following coronary stent implantation (an ESPRIT substudy). Enhanced Suppression of the Platelet IIb/IIIa Receptor with Integrilin TherapyC M Gibson, D J Cohen, E A Cohen, et al.
Circulation|October 25, 2000
TIMI risk score for ST-elevation myocardial infarction: A convenient, bedside, clinical score for risk assessment at presentation: An intravenous nPA for treatment of infarcting myocardium early II trial substudyD A Morrow, E M Antman, A Charlesworth, et al.
Journal of the American College of Cardiology|October 16, 1999
Impaired coronary blood flow in nonculprit arteries in the setting of acute myocardial infarction. The TIMI Study Group. Thrombolysis in myocardial infarctionC M Gibson, K A Ryan, S A Murphy, et al.
The American Journal of Cardiology|November 15, 2000
ST-segment resolution and infarct-related artery patency and flow after thrombolytic therapy. Thrombolysis in Myocardial Infarction (TIMI) 14 investigatorsJ A de Lemos, E M Antman, R P Giugliano, et al.
Circulation|January 19, 2000
Relationship of TIMI myocardial perfusion grade to mortality after administration of thrombolytic drugsC M Gibson, C P Cannon, S A Murphy, et al.
The American Journal of Cardiology|October 26, 2001
Early coronary intervention following pharmacologic therapy for acute myocardial infarction (the combined TIMI 10B-TIMI 14 experience)M J Schweiger, C P Cannon, S A Murphy, et al.
Circulation|April 20, 1999
Relationship between TIMI frame count and clinical outcomes after thrombolytic administration. Thrombolysis In Myocardial Infarction (TIMI) Study GroupC M Gibson, S A Murphy, M J Rizzo, et al.
American Heart Journal|March 29, 2001
Abciximab and early adjunctive percutaneous coronary intervention are associated with improved ST-segment resolution after thrombolysis: Observations from the TIMI 14 TrialJ A de Lemos, C M Gibson, E M Antman, et al.
The American Journal of Cardiology|November 24, 1999
Weight-adjusted dosing of TNK-tissue plasminogen activator and its relation to angiographic outcomes in the thrombolysis in myocardial infarction 10B trial. TIMI 10B InvestigatorsC M Gibson, C P Cannon, S A Murphy, et al.
Pageof 11

Showing results (91-100 of 102) with videos related to

Sort By:
Pageof 11
Transactions of the Royal Society of Tropical Medicine and Hygiene|May 1, 1997
The disposition of intramuscular artemether in children with cerebral malaria; a preliminary studyS A Murphy, E Mberu, D Muhia, et al.
The American Journal of Cardiology|May 30, 2001
Effect of eptifibatide on coronary flow reserve following coronary stent implantation (an ESPRIT substudy). Enhanced Suppression of the Platelet IIb/IIIa Receptor with Integrilin TherapyC M Gibson, D J Cohen, E A Cohen, et al.
Circulation|October 25, 2000
TIMI risk score for ST-elevation myocardial infarction: A convenient, bedside, clinical score for risk assessment at presentation: An intravenous nPA for treatment of infarcting myocardium early II trial substudyD A Morrow, E M Antman, A Charlesworth, et al.
Journal of the American College of Cardiology|October 16, 1999
Impaired coronary blood flow in nonculprit arteries in the setting of acute myocardial infarction. The TIMI Study Group. Thrombolysis in myocardial infarctionC M Gibson, K A Ryan, S A Murphy, et al.
The American Journal of Cardiology|November 15, 2000
ST-segment resolution and infarct-related artery patency and flow after thrombolytic therapy. Thrombolysis in Myocardial Infarction (TIMI) 14 investigatorsJ A de Lemos, E M Antman, R P Giugliano, et al.
Circulation|January 19, 2000
Relationship of TIMI myocardial perfusion grade to mortality after administration of thrombolytic drugsC M Gibson, C P Cannon, S A Murphy, et al.
The American Journal of Cardiology|October 26, 2001
Early coronary intervention following pharmacologic therapy for acute myocardial infarction (the combined TIMI 10B-TIMI 14 experience)M J Schweiger, C P Cannon, S A Murphy, et al.
Circulation|April 20, 1999
Relationship between TIMI frame count and clinical outcomes after thrombolytic administration. Thrombolysis In Myocardial Infarction (TIMI) Study GroupC M Gibson, S A Murphy, M J Rizzo, et al.
American Heart Journal|March 29, 2001
Abciximab and early adjunctive percutaneous coronary intervention are associated with improved ST-segment resolution after thrombolysis: Observations from the TIMI 14 TrialJ A de Lemos, C M Gibson, E M Antman, et al.
The American Journal of Cardiology|November 24, 1999
Weight-adjusted dosing of TNK-tissue plasminogen activator and its relation to angiographic outcomes in the thrombolysis in myocardial infarction 10B trial. TIMI 10B InvestigatorsC M Gibson, C P Cannon, S A Murphy, et al.
Pageof 11